Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancer
Open Access
- 22 July 2008
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 99 (3), 491-501
- https://doi.org/10.1038/sj.bjc.6604486
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Crucial Roles of Sp1 and Epigenetic Modifications in the Regulation of the CLDN4 Promoter in Ovarian Cancer CellsOnline Journal of Public Health Informatics, 2006
- Exploring a New Twist on Tumor MetastasisCancer Research, 2006
- p63/AMACR Antibody Cocktail Restaining of Prostate Needle Biopsy Tissues After Transfer to Charged SlidesAmerican Journal of Clinical Pathology, 2005
- p63/AMACR Antibody Cocktail Restaining of Prostate Needle Biopsy Tissues After Transfer to Charged SlidesAmerican Journal of Clinical Pathology, 2005
- Use of multiple biomarkers for a molecular diagnosis of prostate cancerInternational Journal of Cancer, 2004
- Re: Hessels D, Klein Gunnewiek JMT, van Oort I, Karthaus HFM, van Leenders GJL, van Balken B, Kiemeney LA, Witjes JA, Schalken JA. DD3PCA3-based molecular urine analysis for the diagnosis of prostate cancer. Eur Urol 2003;44:8?16European Urology, 2004
- Claudin 4 Protein Expression in Primary and Metastatic Pancreatic Cancer Support for Use as a Therapeutic TargetAmerican Journal of Clinical Pathology, 2004
- Hepsin is Highly Over Expressed in and a New Candidate for a Prognostic Indicator in Prostate CancerJournal of Urology, 2004
- The Hallmarks of CancerCell, 2000
- Calcium-independent and dependent steps in action of Clostridiumperfringens enterotoxin on HeLa and Vero cellsBiochemical and Biophysical Research Communications, 1979